Trials / Conditions / Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes
Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes
4 registered clinical trials studyying Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After NCT03537599 | Sumithira Vasu | Phase 1 / Phase 2 |
| Completed | High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in P NCT03128359 | City of Hope Medical Center | Phase 2 |
| Terminated | Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic NCT03146871 | University of Southern California | Phase 2 |
| Active Not Recruiting | Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomon NCT02935361 | University of Southern California | Phase 1 / Phase 2 |